An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ, NCT01552057)

PHASE3CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Fibromyalgia
Interventions
DRUG

Duloxetine

Administered Orally

Trial Locations (1)

982-0032

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Miyagi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shionogi

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY